FSMAX
Price
$114.97
Change
+$0.84 (+0.74%)
Updated
Sep 11 closing price
Net Assets
40.07B
OPMSX
Price
$31.56
Change
+$0.15 (+0.48%)
Updated
Sep 11 closing price
Net Assets
2.5B
Interact to see
Advertisement

FSMAX vs OPMSX

FSMAX vs OPMSX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. OPMSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and OPMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. OPMSX (2.5B). FSMAX pays higher dividends than OPMSX: FSMAX (0.49) vs OPMSX (0.16). FSMAX was incepted earlier than OPMSX: FSMAX (15 years) vs OPMSX (27 years). OPMSX (1.04) is less costly to investors than FSMAX (0.04). OPMSX is a more actively managed with annual turnover of: 44.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than OPMSX: FSMAX (0) vs OPMSX (1000). FSMAX annual gain was more profitable for investors over the last year : 13.05 vs. OPMSX (-0.36). FSMAX return over 5 years is better than : 32.77 vs. OPMSX (-2.50).
FSMAXOPMSXFSMAX / OPMSX
Total Expense Ratio0.041.043%
Annual Report Gross Expense Ratio0.041.043%
Fund Existence15 years27 years-
Gain YTD13.3709.290144%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B2.5B1,602%
Annual Yield % from dividends0.490.16300%
Returns for 1 year13.05-0.36-3,668%
Returns for 3 years63.9226.32243%
Returns for 5 years32.77-2.50-1,313%
Returns for 10 years133.4223.11577%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MSMR34.090.15
+0.44%
McElhenny Sheffield Managed Risk ETF
MYHD24.770.04
+0.18%
State Street®My2030 HighYield CrptBdETF
COPX88.53-0.08
-0.09%
Global X Copper Miners ETF
PSQ25.93-0.23
-0.88%
ProShares Short QQQ
BBC49.38-0.53
-1.05%
Virtus LifeSci Biotech Clinical Trls ETF